Page 238 - Multidisipliner Covid 19
P. 238

BÖLÜM  13






             Plasma for Ebola Virus Disease in Guinea. 2018;374(1):33-42.doi:10.1056/
             NEJMoa1511812.Evaluation
         7.  Dean CL, Hooper JW, Dye JM, et al. Characterization of Ebola conva-
             lescent plasma donor immune response and psoralen treated plasma
             in the United States. Transfusion. 2020;60(5):1024-1031.doi:10.1111/trf.
             15739
         8. Arabi YM, Hajeer AH, Luke T, et al. Feasibility of using convalescent
             plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg
             Infect Dis. 2016;22(9):1554-1561. doi:10.3201/eid2209.151164
         9. Devasenapathy N, Ye Z, Loeb M, et al. Efficacy and safety of convales-
             cent plasma for severe COVID-19 based on evidence in other severe
             respiratory viral infections: a systematic review and meta-analysis.
             Can Med Assoc J. Published online 2020:cmaj.200642.doi:10.1503/cmaj.
             200642
         10. Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdan-
             panah Y. Collecting and evaluating convalescent plasma for COVID-
             19 treatment: why and how? Vox Sang. Published online 2020:1-7.doi:
             10.1111/vox.12926
         11.  Wan Y, Shang J, Sun S, et al. Molecular Mechanism for Antibody Depen-
             dent Enhancement of Coronavirus Entry. J Virol. 2019;94(5):1-15. doi:
             10.1128/jvi.02015-19
         12. de Alwis R, Chen S, Gan ES, Ooi EE. Impact of immune enhancement
             on Covid-19 polyclonal hyperimmune globulin therapy and vaccine
             development. EBioMedicine. 2020;55. doi:10.1016/j.ebiom.2020.102768
         13. Tetro JA. Is COVID-19 receiving ADE from other coronaviruses? Mi-
             crobes Infect. 2020;22(2):72-73. doi:10.1016/j.micinf.2020.02.006
         14. Rojas M, Rodríguez Y, Monsalve DM, et al. Since January 2020 Elsevier
             has created a COVID-19 resource centre with free information in English
             and Mandarin on the novel coronavirus COVID- 19 . The COVID-19
             resource centre is hosted on Elsevier Connect , the company ’ s public
             news and information . 2020;(January).
         15. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness
             of convalescent plasma and hyperimmune immunoglobulin for the
             treatment of severe acute respiratory infections of viral etiology: A
             systematic review and exploratory meta-analysis. J Infect Dis.2015;211(1):
             80-90. doi:10.1093/infdis/jiu396
         16. Shen C, Wang Z, Zhao F, et al. Treatment of 5 Critically Ill Patients




                                                                        237
   233   234   235   236   237   238   239   240   241   242   243